Get these test out to everyone!
Abbott announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization for the fastest available molecular point-of-care test for the detection of novel coronavirus, delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW™ platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.
